Literature DB >> 22362266

Cardiac dyssynchrony: we have the tools. It is time to use them.

Steven Port.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22362266     DOI： 10.1007/s12350-012-9526-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  21 in total

1.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

2.  Cardiac-resynchronization therapy for mild-to-moderate heart failure.

Authors:  Anthony S L Tang; George A Wells; Mario Talajic; Malcolm O Arnold; Robert Sheldon; Stuart Connolly; Stefan H Hohnloser; Graham Nichol; David H Birnie; John L Sapp; Raymond Yee; Jeffrey S Healey; Jean L Rouleau
Journal:  N Engl J Med       Date:  2010-11-14       Impact factor: 91.245

3.  Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT?

Authors:  Maureen M Henneman; Ji Chen; Petra Dibbets-Schneider; Marcel P Stokkel; Gabe B Bleeker; Claudia Ypenburg; Ernst E van der Wall; Martin J Schalij; Ernest V Garcia; Jeroen J Bax
Journal:  J Nucl Med       Date:  2007-06-15       Impact factor: 10.057

4.  Optimization and validation of radionuclide angiography phase analysis parameters for quantification of mechanical dyssynchrony.

Authors:  Richard Wassenaar; David O'Connor; Barbora Dej; Terrence David Ruddy; David Birnie
Journal:  J Nucl Cardiol       Date:  2009-07-22       Impact factor: 5.952

5.  A unique method by which to quantitate synchrony with equilibrium radionuclide angiography.

Authors:  J William O'Connell; Carole Schreck; Michael Moles; Nitish Badwar; Theresa DeMarco; Jeffrey Olgin; Byron Lee; Zian Tseng; Uday Kumar; Elias H Botvinick
Journal:  J Nucl Cardiol       Date:  2005 Jul-Aug       Impact factor: 5.952

6.  The performance of phase analysis of gated SPECT myocardial perfusion imaging in the presence of perfusion defects: a simulation study.

Authors:  Alice Cheung; Yanli Zhou; Tracy L Faber; Ernest V Garcia; Lei Zhu; Ji Chen
Journal:  J Nucl Cardiol       Date:  2011-12-28       Impact factor: 5.952

7.  Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.

Authors:  Anne-Catherine Pouleur; Dorit Knappe; Amil M Shah; Hajime Uno; Mikhail Bourgoun; Elyse Foster; Scott McNitt; W Jackson Hall; Wojciech Zareba; Ilan Goldenberg; Arthur J Moss; Marc A Pfeffer; Scott D Solomon
Journal:  Eur Heart J       Date:  2011-05-24       Impact factor: 29.983

Review 8.  Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators.

Authors:  L A Saxon; J P Boehmer; J Hummel; S Kacet; T De Marco; G Naccarelli; E Daoud
Journal:  Am J Cardiol       Date:  1999-03-11       Impact factor: 2.778

9.  Interventricular delay measurement using equilibrium radionuclide angiography before resynchronization therapy should be performed outside the area of segmental wall motion abnormalities.

Authors:  Maxime Courtehoux; Noura Zannad; Laurent Fauchier; Dominique Babuty; Veronique Eder
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-10-09       Impact factor: 9.236

10.  Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).

Authors:  Martin G St John Sutton; Ted Plappert; Kathryn E Hilpisch; William T Abraham; David L Hayes; Edward Chinchoy
Journal:  Circulation       Date:  2006-01-09       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.